AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05246670 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05815147 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fortified Powdered Beverage
Description: Participants will be asked to take the fortified powdered beverage everyday for 6 weeks.
Study NCT05117268 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Glass ionomer restoration
Description: The lesions of control group glass ionomer restoration group will be treated according to following clinical protocol: (A) Isolation of treatment area using cotton rolls and saliva ejectors; (B) Carious lesion excavation using high speed handpiece; (C) High viscosity glass ionomer cement mixed following manufacturer's instructions; (D) Cavity will be slightly overfilled using a flat plastic instrument, the occlusal surface will be protected with Vaseline and gloved finger will be used to apply slight pressure for 30s. Postoperative instructions will be clearly explained to each patient caregiver.
Study NCT05117268 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hall technique
Description: In Hall technique, correct size preformed metal crown will be selected and shall be placed without caries excavation. The crown will be filled with glass ionomer cement and seated with finger pressure. Local anesthesia was not used finger pressure was maintained on the crown until the glass ionomer cement was set.
Study NCT05165108 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vagal Nerve Stimulator
Description: A handheld device which consists of a battery powered portable stimulator with a digital control user interface that controls signal amplitude and two steel contact electrodes will deliver the nVNS electrical stimulation to the cervical Vagus nerve. The device has been approved by the U.S. Food and Drug Administration (FDA) for non-invasive Vagus nerve stimulator therapy for adjunctive use for the prevention and treatment of migraine and cluster headaches in adult patients.
Study NCT04974957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1701；BP102
Description: Drug: SHR-1701 IV infusion~Drug: BP102 IV infusion
Study NCT04356924 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychological treatment
Description: The treatment is an adjusted (to the cognitively impaired individual) combination of CBT, ACT, validation strategies, and psychoeducation. One focus is to increase motivation to lifestyle changes, and to a larger degree live life in correspondence with internal goals.
Study NCT04356924 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive training
Description: Computer based training tasks implemented with adaptive intensity. The cognitive training method that will be used is mainly related to executive control (i.e., ability to coordinate thoughts and actions in accordance with internal goals).
Study NCT06411249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belimumab (GSK1550188)
Description: GSK1550188 will be administered subcutaneously.
Study NCT06559826 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: Following screening and baseline assessments, individuals randomized to KAP will undergo a preparatory session prior to the first day of dosing. Participants will complete a sequence of four to five intramuscular (IM) ketamine assisted therapy sessions.
Study NCT06559826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Following screening and baseline assessments, individuals randomized to KAP will undergo a preparatory session prior to the first day of dosing. Participants will complete a sequence of four to five intramuscular (IM) ketamine assisted therapy sessions.
Study NCT06559826 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Description: Each week following KAP, there will be a separate 60-minute integration session 1-6 days afterwards. Integration sessions will focus on processing experiences and material that emerged in KAP sessions (such as assimilating challenging experiences, making meaning of experiences and imagery, working through memories and emotions, and exploring emerging relational patterns) as well as strengthening insights. Within one week of the completion of all KAP sessions, there will be one additional integration session focused on consolidating the insights and improvements gained from KAP treatment.
Study NCT06382636 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard Care
Description: This group will utilize standard care with respect to healthcare provider practices.
Study NCT06382636 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Obstetric Prenatal Genetic Testing Engagement Solution (OPUS) AI Chatbot
Description: This group will be exposed to the AI enabled healthcare chatbot.
Study NCT05374798 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heart Rate Variability-Biofeedback (HRV-B) via Smartwatch Device Intervention
Description: Participants will wear activity trackers equipped with continuous ambulatory physiological monitoring and geolocation. Ecological momentary assessment (EMA; 4 times daily plus optional event-triggered reports) of alcohol use, couple conflict including IPV, and affect will be completed via smartphone application for 28 days. During days 21-28, participants will also be prompted to complete a 10 minute self-administered HRV-B session at least once daily. Subjective usability, feasibility, and acceptability of HRV-B will be assessed. HRV-B will guide participants in an evidence-based paced breathing technique (about 6 breaths per minutes) using visualization on thier mobile device of thier real-time respiratory and cardiac parameters.~During days 21-28, participants will also be prompted to complete a 10 minute self-administered HRV-B session at least once daily. Subjective usability, feasibility, and acceptability of HRV-B will be assessed.
Study NCT04755153 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Practice Facilitation
Description: Tailored interventions provided by a trained Practice Facilitator
Study NCT04755153 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-Practice Facilitation
Description: Implementation support without using Practice Facilitation
Study NCT05840159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxycycline
Description: Doxycycline is a synthetic tetracycline derivative with similar antimicrobial activity.
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLS-010
Description: IV infusion
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: IV infusion
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV infusion
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: IV infusion
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: paclitaxel
Description: IV infusion
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: IV infusion
Study NCT05840159 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxycycline
Description: Doxycycline is a synthetic tetracycline derivative with similar antimicrobial activity.
Study NCT05840159 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT05358470 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise therapy and adapted physical activity-based program
Description: Exercise therapy and adapted physical activity program based on racket sports
Study NCT05792696 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PPI guided strategies
Description: For targeted MAP or lower, if PPI\<1, more fluid therapy. if PPI>3, vasoconstriction therapy. For MAP\<65mmHg and 1\<=PPI\<3, test bolus of 250 ml crystalloid fluid.
Study NCT05792696 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Empirical strategies
Description: Fluid therapy or vasoconstriction depended on experiences of anesthetic staffs.
Study NCT05422625 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PTNS Treatment
Description: Patients will be placed in a comfortable position, sitting or supine. The treatment leg will be propped up comfortably on a footrest but draped and out of view from the patient. A 34-gauge needle electrode will be inserted at a 60-degree angle 5 cm cephalad to the medial malleolus and slightly posterior to the tibia. A PTNS surface electrode will be placed on the ipsilateral calcaneus as well as 2 inactive sham surface electrodes, 1 under the little toe and 1 on the top of the foot. When the PTNS lead set is connected to the Urgent PC stimulator, a current level of 0.5 to 9 mA at 20 Hz is selected based on each patient's foot and plantar motor and sensory responses. Treatment lasts 30 minutes and given once weekly for 12 consecutive weeks.
Study NCT05422625 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham PTNS Treatment
Description: Patients will be positioned similarly as PTNS patients. A Streitberger needle will be used at the tibial nerve insertion site as described above to simulate needle placement. Three electrodes will be placed on the patient's foot, two active TENS electrodes and one inactive TENS electrode. The TENS grounding pad will be a gel electrode pad from a TENS unit device that is placed on the bottom of the foot just below the smallest toe. Another gel electrode will be placed on the top of the foot just above the small toe for conduction. These two electrodes will be connected to the TENS unit lead wires for sham stimulation. A third, inactive, gel electrode, will be placed near the medial aspect of the calcaneus to mimic the PTNS treatment. The TENS electrode will be connected by lead wires to the TENS unit set at 20 HZ. The TENS unit will be turned on and stimulation slowly increased to the patient's first sensory level and then turned off.
Study NCT05241028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ensartinib
Description: Ensartinib 225mg oral daily for 3 years or until recurrence of the disease or intolerable toxicity
Study NCT05519319 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: RFA
Description: RFA will be performed
Study NCT05519319 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PDT
Description: PDT will be performed
Study NCT05519319 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: RFA combined with PDT
Description: RFA and PDT will be performed
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: cisplatin
Description: IV infusion
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: IV infusion
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: carboplatin
Description: IV infusion
Study NCT05798819 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: bevacizumab
Description: IV infusion
Study NCT05412836 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AqueousJoint
Description: AqueousJoint is a liposomal boundary lubricant, which coats the cartilage surface and protects it from further damage and degradation.
Study NCT04276779 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcohol administration
Description: Participants in the alcoholic beverage group will be provided a dose of 95% alcohol (0.99g/kg for males and 0.90 g/kg for females body weight) distributed in two equally spaced beverages (mixed with orange juice 1:5 ratio). This dose will produce a breath alcohol content ranging between .08-.10.
Study NCT04276779 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol administration
Description: Participants in the alcoholic beverage group will be provided a dose of 95% alcohol (0.99g/kg for males and 0.90 g/kg for females body weight) distributed in two equally spaced beverages (mixed with orange juice 1:5 ratio). This dose will produce a breath alcohol content ranging between .08-.10.
Study NCT04276779 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo administration
Description: Individuals in the placebo condition will receive orange juice with 4 ml of alcohol layered on top of the juice. Ethanol will be sprayed on the rims of the glasses.
Study NCT04276779 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Positive mood induction
Description: Participants will be randomized to either positive mood induction procedure. Both conditions involve listening to music that reliably induces positive mood, while simultaneously reading self-referent statements that also induce either positive mood. This procedure lasts about 10 minutes and produces a transient mood state that passes by the end of the study.
Study NCT04276779 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Positive mood induction
Description: Participants will be randomized to either positive mood induction procedure. Both conditions involve listening to music that reliably induces positive mood, while simultaneously reading self-referent statements that also induce either positive mood. This procedure lasts about 10 minutes and produces a transient mood state that passes by the end of the study.
Study NCT04276779 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Negative mood induction
Description: Participants will be randomized to either negative mood induction procedure. Both conditions involve listening to music that reliably induces sad mood, while simultaneously reading self-referent statements that also induce either sad mood. This procedure lasts about 10 minutes and produces a transient mood state that passes by the end of the study.
Study NCT04276779 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Negative mood induction
Description: Participants will be randomized to either negative mood induction procedure. Both conditions involve listening to music that reliably induces sad mood, while simultaneously reading self-referent statements that also induce either sad mood. This procedure lasts about 10 minutes and produces a transient mood state that passes by the end of the study.
Study NCT05628129 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: smartphone application service and phone reminder
Description: smartphone application service and phone reminder for appointments of parents of congenital ectopia lentis patients
Study NCT05612594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bexagliflozin 20 mg
Description: 15mg once daily
Study NCT05612594 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching placebo once daily
Study NCT04771481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Description: Metoclopramide 10 mg + NSS 10 ml intravenous slowly push in 5min before endoscopy 30-120 min
Study NCT04771481 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline 10 mL Injection
Description: Normal saline 10 ml intravenous slowly push in 5min before endoscopy 30-120 min
Study NCT05549089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Insignia™ twin brackets
Description: it is metal orthodontic twin brackets with customized base and individual arch-wires for each patient
Study NCT05549089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Maestro® 3D Ortho Studio software (Discovery, Dentaurum®, Ispringen, Germany)
Description: it is conventional metal orthodontic twin brackets will be customizing the bracket base with adhesive composite, individual arch-wires for each patient and 3D printing indirect bonding tray
Study NCT05549089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ray set® device (Discovery, Dentaurum®, Ispringen, Germany)
Description: it is conventional metal orthodontic twin brackets will be customizing the bracket base with adhesive composite, individual arch-wires for each patient and double-layer vacuum-formed thermoplastic indirect bonding tray
Study NCT05818072 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: One biopsy
Description: To do one biopsy at the proximal part of the longest columnar-lined esophagus.
Study NCT05818072 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Three biopsy
Description: To do three biopsy at the proximal, middle and distal part of the longest columnar-lined esophagus.
Study NCT05818072 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Seattle protocol
Description: To do 4-quadrant biopsy every 1-2 cm at the esophagogastric junction. Seattle protocol has been considered as the gold standard biopsy protocol for patients with suspected Barrett's Esophagus.
Study NCT05818072 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endoscopy
Description: The participants will receive meticulous endoscopic examination with narrow-band imaging.
Study NCT05818072 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Endoscopy
Description: The participants will receive meticulous endoscopic examination with narrow-band imaging.
Study NCT05818072 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopy
Description: The participants will receive meticulous endoscopic examination with narrow-band imaging.
Study NCT04833790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Free distribution of ORS
Description: Provides will receive 3 months supply of ORS at the beginning of the study to dispense to their patients. They will be asked to dispense the ORS at the market rate and not to give it away to other providers.
Study NCT04008628 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous Oxide
Description: Inhalation of a 50%/50% nitrous oxide/oxygen mixture (Kalinox®)
Study NCT04549103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise program
Description: Baduanjin (BDJ), also known as Eight-Section Brocades, is one of the forms of traditional Chinese Qigong exercises, characterized by symmetrical physical posture, movements, mindfulness, and breathing. Its primary focus is on the release of 'Qi' or internal body energy with the intent of improving health outcomes. BDJ encompasses eight simple movements involving combinations of postures, meditation, slow relaxing movements, and breathing exercises. It is a low intensity exercise, which have been found to improve range of motion, strength and general health. The simplicity and low intensity level is ideal for older adults to practice at home using instructional videos.
Study NCT06214351 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Use of mobile midwifery application
Description: Pregnant women in the experimental group will have a mobile midwifery application installed on their smartphones. The pregnant woman will be able to reach the research midwife 24/7. With the informative content and algorithm mechanism in the application, she will be able to provide individual care and detect early signs of danger, enabling her to seek medical attention.
Study NCT04833790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with ORS preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who requests ORS to treat their child's diarrhea.
Study NCT04833790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with Antibiotic preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who requests Antibiotics to treat their child's diarrhea.
Study NCT04833790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with no preference
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who does not request anything specific to treat their child's diarrhea.
Study NCT04833790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient with no preference + no financial incentive
Description: Providers will receive a visit from an anonymous standardize patient posing a caretaker for a child with diarrhea who does not request anything specific to treat their child's diarrhea. In addition they will inform the provider that they are not going to purchase anything from the provider because they have an uncle with a drug shop where they can get a discount.
Study NCT04959591 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous acetaminophen
Description: experimental(pre): administration of IV acetaminophen
Study NCT04959591 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous acetaminophen
Description: experimental(post): administration of IV acetaminophen
Study NCT04959591 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo comparator: administration of normal saline
Study NCT04987346 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking on an instrumented treadmill
Description: Participants will be asked to walk at different gait velocities for 1 minute. The treadmill speed will be increased incrementally at 0.1m/s intervals until just before running.
Study NCT04987346 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking on an instrumented treadmill while dual-tasking
Description: Participants aged between 6 and 17 years will be asked to walk at comfortable walking speed while playing either a cognitive (Stroop Color and Word Test) or motor (requiring arm swing) game.
Study NCT05473390 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: functional electrical stimulation
Description: functional electrical stimulation on back muscles
Study NCT05473390 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: kinesotaping
Description: no intervention